{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:42:17Z","timestamp":1792460537392,"version":"4.5.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-81277-2","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T20:36:58Z","timestamp":1735331818000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Prediction of late-onset preeclampsia using plasma proteomics: a longitudinal multi-cohort study"],"prefix":"10.1038","volume":"14","author":[{"given":"Ina J.","family":"Andresen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Zucknick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maren-Helene L.","family":"Degnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Angst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Aghaeepour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Cecilie P.","family":"Roland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi L.","family":"Tarca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ane Cecilie","family":"Westerberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trond M.","family":"Michelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,28]]},"reference":[{"key":"81277_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2147\/IJWH.S8550","volume":"2","author":"JA Turner","year":"2010","unstructured":"Turner, J. A. Diagnosis and management of pre-eclampsia: an update. Int. J. Womens Health 2, 327\u2013337. https:\/\/doi.org\/10.2147\/IJWH.S8550 (2010).","journal-title":"Int. J. Womens Health"},{"key":"81277_CR2","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1097\/AOG.0b013e3181a45b25","volume":"113","author":"EV Kuklina","year":"2009","unstructured":"Kuklina, E. V., Ayala, C. & Callaghan, W. M. Hypertensive disorders and severe obstetric morbidity in the United States. Obstet. Gynecol. 113, 1299\u20131306. https:\/\/doi.org\/10.1097\/AOG.0b013e3181a45b25 (2009).","journal-title":"Obstet. Gynecol."},{"key":"81277_CR3","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1136\/bmj.309.6966.1395","volume":"309","author":"KA Douglas","year":"1994","unstructured":"Douglas, K. A. & Redman, C. W. Eclampsia in the United Kingdom. BMJ 309, 1395\u20131400. https:\/\/doi.org\/10.1136\/bmj.309.6966.1395 (1994).","journal-title":"BMJ"},{"key":"81277_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1053\/j.semperi.2011.09.011","volume":"36","author":"L Ghulmiyyah","year":"2012","unstructured":"Ghulmiyyah, L. & Sibai, B. Maternal mortality from preeclampsia\/eclampsia. Semin Perinatol. 36, 56\u201359. https:\/\/doi.org\/10.1053\/j.semperi.2011.09.011 (2012).","journal-title":"Semin Perinatol."},{"key":"81277_CR5","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1111\/aogs.13357","volume":"97","author":"LT Nyflot","year":"2018","unstructured":"Nyflot, L. T., Ellingsen, L., Yli, B. M., Oian, P. & Vangen, S. Maternal deaths from hypertensive disorders: lessons learnt. Acta Obstet. Gynecol. Scand. 97, 976\u2013987. https:\/\/doi.org\/10.1111\/aogs.13357 (2018).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"81277_CR6","doi-asserted-by":"publisher","first-page":"S907","DOI":"10.1016\/j.ajog.2020.09.047","volume":"226","author":"CWG Redman","year":"2022","unstructured":"Redman, C. W. G., Staff, A. C. & Roberts, J. M. Syncytiotrophoblast stress in preeclampsia: The convergence point for multiple pathways. Am. J. Obstet. Gynecol. 226, S907\u2013S927. https:\/\/doi.org\/10.1016\/j.ajog.2020.09.047 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"81277_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","volume":"72","author":"MA Brown","year":"2018","unstructured":"Brown, M. A. et al. Hypertensive disorders of pregnancy: isshp classification, diagnosis, and management recommendations for international practice. Hypertension 72, 24\u201343. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.10803 (2018).","journal-title":"Hypertension"},{"key":"81277_CR8","unstructured":"August, P. & Sibai, B. M. Preeclampsia: Clinical features and diagnosis, <https:\/\/www.medilib.ir\/uptodate\/show\/6814> (2022)."},{"key":"81277_CR9","first-page":"2317","volume":"70","author":"LK Wagner","year":"2004","unstructured":"Wagner, L. K. Diagnosis and management of Preeclampsia. Am. Fam. Phys. 70, 2317\u20132324 (2004).","journal-title":"Am. Fam. Phys."},{"key":"81277_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.bpobgyn.2011.02.007","volume":"25","author":"PJ Williams","year":"2011","unstructured":"Williams, P. J. & Broughton Pipkin, F. The genetics of pre-eclampsia and other hypertensive disorders of pregnancy. Best Pract. Res. Clin. Obstet. Gynaecol. 25, 405\u2013417. https:\/\/doi.org\/10.1016\/j.bpobgyn.2011.02.007 (2011).","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"81277_CR11","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/j.bbadis.2012.08.004","volume":"1822","author":"J Jebbink","year":"2012","unstructured":"Jebbink, J. et al. Molecular genetics of preeclampsia and HELLP syndrome - a review. Biochim. Biophys. Acta 1822, 1960\u20131969. https:\/\/doi.org\/10.1016\/j.bbadis.2012.08.004 (2012).","journal-title":"Biochim. Biophys. Acta"},{"key":"81277_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.10.047","author":"L Myatt","year":"2020","unstructured":"Myatt, L. The prediction of preeclampsia: the way forward. Am. J. Obstet. Gynecol. https:\/\/doi.org\/10.1016\/j.ajog.2020.10.047 (2020).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"81277_CR13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00404-015-3671-8","volume":"292","author":"Y Liu","year":"2015","unstructured":"Liu, Y. et al. Diagnostic accuracy of the soluble Fms-like tyrosine kinase-1\/placental growth factor ratio for preeclampsia: a meta-analysis based on 20 studies. Arch. Gynecol. Obstet. 292, 507\u2013518. https:\/\/doi.org\/10.1007\/s00404-015-3671-8 (2015).","journal-title":"Arch. Gynecol. Obstet."},{"key":"81277_CR14","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.jogc.2017.07.014","volume":"40","author":"AM Yusuf","year":"2018","unstructured":"Yusuf, A. M., Kahane, A. & Ray, J. G. First and Second Trimester Serum sFlt-1\/PlGF Ratio and Subsequent Preeclampsia: A Systematic Review. J. Obstet. Gynaecol. Can. 40, 618\u2013626. https:\/\/doi.org\/10.1016\/j.jogc.2017.07.014 (2018).","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"81277_CR15","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1161\/hypertensionaha.117.10182","volume":"71","author":"S Agrawal","year":"2018","unstructured":"Agrawal, S., Cerdeira, A. S., Redman, C. & Vatish, M. Meta-Analysis and Systematic Review to Assess the Role of Soluble FMS-Like Tyrosine Kinase-1 and Placenta Growth Factor Ratio in Prediction of Preeclampsia: The SaPPPhirE Study. Hypertension 71, 306\u2013316. https:\/\/doi.org\/10.1161\/hypertensionaha.117.10182 (2018).","journal-title":"Hypertension"},{"key":"81277_CR16","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1161\/hypertensionaha.119.13360","volume":"74","author":"S Agrawal","year":"2019","unstructured":"Agrawal, S., Shinar, S., Cerdeira, A. S., Redman, C. & Vatish, M. Predictive Performance of PlGF (Placental Growth Factor) for Screening Preeclampsia in Asymptomatic Women: A Systematic Review and Meta-Analysis. Hypertension 74, 1124\u20131135. https:\/\/doi.org\/10.1161\/hypertensionaha.119.13360 (2019).","journal-title":"Hypertension"},{"key":"81277_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1414838","volume":"374","author":"H Zeisler","year":"2016","unstructured":"Zeisler, H. et al. Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. N. Engl. J. Med. 374, 13\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1414838 (2016).","journal-title":"N. Engl. J. Med."},{"key":"81277_CR18","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1161\/HYPERTENSIONAHA.116.08620","volume":"69","author":"U Sovio","year":"2017","unstructured":"Sovio, U. et al. Prediction of Preeclampsia Using the Soluble fms-Like Tyrosine Kinase 1 to Placental Growth Factor Ratio: A Prospective Cohort Study of Unselected Nulliparous Women. Hypertension 69, 731\u2013738. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.116.08620 (2017).","journal-title":"Hypertension"},{"key":"81277_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2021.01.020","author":"AL Tarca","year":"2022","unstructured":"Tarca, A. L. et al. Prediction of preeclampsia throughout gestation with maternal characteristics and biophysical and biochemical markers: a longitudinal study. Am. J. Obstet. Gynecol. https:\/\/doi.org\/10.1016\/j.ajog.2021.01.020 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"81277_CR20","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nm1429","volume":"12","author":"S Venkatesha","year":"2006","unstructured":"Venkatesha, S. et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat. Med. 12, 642\u2013649. https:\/\/doi.org\/10.1038\/nm1429 (2006).","journal-title":"Nat. Med."},{"key":"81277_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2024.03.012","author":"AC Westerberg","year":"2024","unstructured":"Westerberg, A. C., Degnes, M. L., Andresen, I. J., Roland, M. C. P. & Michelsen, T. M. Angiogenic and vasoactive proteins in the maternal-fetal interface in healthy pregnancies and preeclampsia. Am. J. Obstet. Gynecol. https:\/\/doi.org\/10.1016\/j.ajog.2024.03.012 (2024).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"81277_CR22","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1056\/NEJMoa031884","volume":"350","author":"RJ Levine","year":"2004","unstructured":"Levine, R. J. et al. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 350, 672\u2013683. https:\/\/doi.org\/10.1056\/NEJMoa031884 (2004).","journal-title":"N. Engl. J. Med."},{"key":"81277_CR23","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1056\/NEJMoa055352","volume":"355","author":"RJ Levine","year":"2006","unstructured":"Levine, R. J. et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N. Engl. J. Med. 355, 992\u20131005. https:\/\/doi.org\/10.1056\/NEJMoa055352 (2006).","journal-title":"N. Engl. J. Med."},{"key":"81277_CR24","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/01.AOG.0000249609.04831.7c","volume":"109","author":"M Widmer","year":"2007","unstructured":"Widmer, M. et al. Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review. Obstet. Gynecol. 109, 168\u2013180. https:\/\/doi.org\/10.1097\/01.AOG.0000249609.04831.7c (2007).","journal-title":"Obstet. Gynecol."},{"key":"81277_CR25","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/j.1471-0528.2012.03311.x","volume":"119","author":"CE Kleinrouweler","year":"2012","unstructured":"Kleinrouweler, C. E. et al. Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis. BJOG 119, 778\u2013787. https:\/\/doi.org\/10.1111\/j.1471-0528.2012.03311.x (2012).","journal-title":"BJOG"},{"key":"81277_CR26","doi-asserted-by":"publisher","first-page":"e944104","DOI":"10.12659\/MSM.944104","volume":"30","author":"J Tomkiewicz","year":"2024","unstructured":"Tomkiewicz, J. & Darmochwal-Kolarz, D. A. Biomarkers for Early Prediction and Management of Preeclampsia: A Comprehensive Review. Med. Sci. Monit. 30, e944104 (2024).","journal-title":"Med. Sci. Monit."},{"key":"81277_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2022.11.001","author":"T Chaiworapongsa","year":"2023","unstructured":"Chaiworapongsa, T. et al. Preeclampsia at term can be classified into 2 clusters with different clinical characteristics and outcomes based on angiogenic biomarkers in maternal blood. Am. J. Obstetr. Gynecol. https:\/\/doi.org\/10.1016\/j.ajog.2022.11.001 (2023).","journal-title":"Am. J. Obstetr. Gynecol."},{"key":"81277_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181468","author":"O Erez","year":"2017","unstructured":"Erez, O. et al. The prediction of late-onset preeclampsia: Results from a longitudinal proteomics study. Plos One https:\/\/doi.org\/10.1371\/journal.pone.0181468 (2017).","journal-title":"Plos One"},{"key":"81277_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217273","author":"AL Tarca","year":"2019","unstructured":"Tarca, A. L. et al. The prediction of early preeclampsia: Results from a longitudinal proteomics study. Plos One https:\/\/doi.org\/10.1371\/journal.pone.0217273 (2019).","journal-title":"Plos One"},{"key":"81277_CR30","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2021.1888915","author":"MS Ghaemi","year":"2021","unstructured":"Ghaemi, M. S. et al. Proteomic signatures predict preeclampsia in individual cohorts but not across cohorts \u2013 implications for clinical biomarker studies. J. Mater. Fetal Neonatal Med. https:\/\/doi.org\/10.1080\/14767058.2021.1888915 (2021).","journal-title":"J. Mater. Fetal Neonatal Med."},{"key":"81277_CR31","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1097\/AOG.0000000000000293","volume":"123","author":"EW Triche","year":"2014","unstructured":"Triche, E. W. et al. Bioinformatic approach to the genetics of preeclampsia. Obstet. Gynecol. 123, 1155\u20131161. https:\/\/doi.org\/10.1097\/AOG.0000000000000293 (2014).","journal-title":"Obstet. Gynecol."},{"key":"81277_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2014.49","author":"JC Rohloff","year":"2014","unstructured":"Rohloff, J. C. et al. Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents. Mol. Ther.-Nucl. Acids. https:\/\/doi.org\/10.1038\/mtna.2014.49 (2014).","journal-title":"Mol. Ther.-Nucl. Acids."},{"key":"81277_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015004","author":"L Gold","year":"2010","unstructured":"Gold, L. et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. Plos One https:\/\/doi.org\/10.1371\/journal.pone.0015004 (2010).","journal-title":"Plos One"},{"key":"81277_CR34","doi-asserted-by":"publisher","first-page":"19971","DOI":"10.1073\/pnas.1213933109","volume":"109","author":"DR Davies","year":"2012","unstructured":"Davies, D. R. et al. Unique motifs and hydrophobic interactions shape the binding of modified DNA ligands to protein targets. P. Natl. Acad. Sci. USA 109, 19971\u201319976. https:\/\/doi.org\/10.1073\/pnas.1213933109 (2012).","journal-title":"P. Natl. Acad. Sci. USA"},{"key":"81277_CR35","unstructured":"SomaLogic. Technical white paper, <https:\/\/somalogic.com\/wp-content\/uploads\/2017\/06\/SSM-002-Technical-White-Paper_010916_LSM1.pdf> (2017)."},{"key":"81277_CR36","unstructured":"SomaLogic, I. Technical White Paper. (somalogic.com, 2016)."},{"key":"81277_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-13-136","author":"AL Tarca","year":"2012","unstructured":"Tarca, A. L., Draghici, S., Bhatti, G. & Romero, R. Down-weighting overlapping genes improves gene set analysis. Bmc Bioinform. https:\/\/doi.org\/10.1186\/1471-2105-13-136 (2012).","journal-title":"Bmc Bioinform."},{"key":"81277_CR38","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s42003-019-0315-8","volume":"2","author":"W Lin","year":"2019","unstructured":"Lin, W. et al. Peptidyl prolyl cis\/trans isomerase activity on the cell surface correlates with extracellular matrix development. Commun. Biol. 2, 58. https:\/\/doi.org\/10.1038\/s42003-019-0315-8 (2019).","journal-title":"Commun. Biol."},{"key":"81277_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000439","volume":"8","author":"TL Davis","year":"2010","unstructured":"Davis, T. L. et al. Structural and biochemical characterization of the human cyclophilin family of peptidyl-prolyl isomerases. PLoS Biol. 8, e1000439. https:\/\/doi.org\/10.1371\/journal.pbio.1000439 (2010).","journal-title":"PLoS Biol."},{"key":"81277_CR40","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1177\/1535370220938741","volume":"245","author":"BB O'Connor","year":"2020","unstructured":"O\u2019Connor, B. B., Pope, B. D., Peters, M. M., Ris-Stalpers, C. & Parker, K. K. The role of extracellular matrix in normal and pathological pregnancy: Future applications of microphysiological systems in reproductive medicine. Exp. Biol. Med. (Maywood) 245, 1163\u20131174. https:\/\/doi.org\/10.1177\/1535370220938741 (2020).","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"81277_CR41","doi-asserted-by":"publisher","first-page":"23654","DOI":"10.1038\/s41598-024-73796-9","volume":"14","author":"ML Degnes","year":"2024","unstructured":"Degnes, M. L. et al. Protein biomarker signatures of preeclampsia - a longitudinal 5000-multiplex proteomics study. Sci. Rep. 14, 23654. https:\/\/doi.org\/10.1038\/s41598-024-73796-9 (2024).","journal-title":"Sci. Rep."},{"key":"81277_CR42","doi-asserted-by":"publisher","first-page":"148","DOI":"10.4255\/mcpharmacol.09.19","volume":"1","author":"K Lui","year":"2009","unstructured":"Lui, K. & Huang, Y. RanGTPase: A Key Regulator of Nucleocytoplasmic Trafficking. Mol. Cell. Pharmacol. 1, 148\u2013156. https:\/\/doi.org\/10.4255\/mcpharmacol.09.19 (2009).","journal-title":"Mol. Cell. Pharmacol."},{"key":"81277_CR43","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1242\/jcs.03071","volume":"119","author":"J Joseph","year":"2006","unstructured":"Joseph, J. Ran at a glance. J. Cell. Sci. 119, 3481\u20133484. https:\/\/doi.org\/10.1242\/jcs.03071 (2006).","journal-title":"J. Cell. Sci."},{"key":"81277_CR44","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/jcb.1269","volume":"84","author":"P Phillips","year":"2001","unstructured":"Phillips, P. & Thomson, M. Small GTP-binding proteins in the nuclei of human placenta. J. Cell Biochem. 84, 100\u2013107. https:\/\/doi.org\/10.1002\/jcb.1269 (2001).","journal-title":"J. Cell Biochem."},{"key":"81277_CR45","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1006\/cbir.2001.0823","volume":"26","author":"I Kuyznierewicz","year":"2002","unstructured":"Kuyznierewicz, I. & Thomson, M. GTP-binding proteins G(salpha), G(ialpha), and Ran identified in mitochondria of human placenta. Cell. Biol. Int. 26, 99\u2013108. https:\/\/doi.org\/10.1006\/cbir.2001.0823 (2002).","journal-title":"Cell. Biol. Int."},{"key":"81277_CR46","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s10020-018-0047-0","volume":"24","author":"GH Sack Jr","year":"2018","unstructured":"Sack, G. H. Jr. Serum amyloid A - a review. Mol. Med. 24, 46. https:\/\/doi.org\/10.1186\/s10020-018-0047-0 (2018).","journal-title":"Mol. Med."},{"key":"81277_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090881","author":"S Sandri","year":"2014","unstructured":"Sandri, S. et al. Serum amyloid A in the placenta and its role in trophoblast invasion. Plos One https:\/\/doi.org\/10.1371\/journal.pone.0090881 (2014).","journal-title":"Plos One"},{"key":"81277_CR48","doi-asserted-by":"publisher","first-page":"5585","DOI":"10.4049\/jimmunol.177.8.5585","volume":"177","author":"MS Lee","year":"2006","unstructured":"Lee, M. S. et al. Serum amyloid A binding to formyl peptide receptor-like 1 induces synovial hyperplasia and angiogenesis. J. Immunol. 177, 5585\u20135594. https:\/\/doi.org\/10.4049\/jimmunol.177.8.5585 (2006).","journal-title":"J. Immunol."},{"key":"81277_CR49","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1039\/d0mo00074d","volume":"16","author":"MT Odenkirk","year":"2020","unstructured":"Odenkirk, M. T. et al. Unveiling molecular signatures of preeclampsia and gestational diabetes mellitus with multi-omics and innovative cheminformatics visualization tools. Mol. Omics 16, 521\u2013532. https:\/\/doi.org\/10.1039\/d0mo00074d (2020).","journal-title":"Mol. Omics"},{"key":"81277_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2022.109396","author":"X Guan","year":"2022","unstructured":"Guan, X. et al. Elevated trophoblastic Siglec6 contributes to the impairment of vascular endothelial cell functions by downregulating Wnt6\/beta-catenin signaling in preeclampsia. Arch. Biochem. Biophys. https:\/\/doi.org\/10.1016\/j.abb.2022.109396 (2022).","journal-title":"Arch. Biochem. Biophys."},{"key":"81277_CR51","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.placenta.2016.02.015","volume":"40","author":"MM Liang","year":"2016","unstructured":"Liang, M. M. et al. Gene expression profiling reveals different molecular patterns in G-protein coupled receptor signaling pathways between early- and late-onset preeclampsia. Placenta 40, 52\u201359. https:\/\/doi.org\/10.1016\/j.placenta.2016.02.015 (2016).","journal-title":"Placenta"},{"key":"81277_CR52","doi-asserted-by":"publisher","first-page":"37118","DOI":"10.1074\/jbc.M111.233841","volume":"286","author":"KK Lam","year":"2011","unstructured":"Lam, K. K. et al. Glycodelin-A protein interacts with Siglec-6 protein to suppress trophoblast invasiveness by down-regulating extracellular signal-regulated kinase (ERK)\/c-Jun signaling pathway. J. Biol. Chem. 286, 37118\u201337127. https:\/\/doi.org\/10.1074\/jbc.M111.233841 (2011).","journal-title":"J. Biol. Chem."},{"key":"81277_CR53","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/bs.apha.2017.08.002","volume":"81","author":"X Wang","year":"2018","unstructured":"Wang, X. & Khalil, R. A. Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease. Adv. Pharmacol. 81, 241\u2013330. https:\/\/doi.org\/10.1016\/bs.apha.2017.08.002 (2018).","journal-title":"Adv. Pharmacol."},{"key":"81277_CR54","doi-asserted-by":"publisher","first-page":"H687","DOI":"10.1152\/ajpheart.00374.2017","volume":"313","author":"CA Foote","year":"2017","unstructured":"Foote, C. A. & Martinez-Lemus, L. A. Uncovering novel roles for matrix metalloproteinases in preeclampsia. Am. J. Physiol. Heart. Circ. Physiol. 313, H687\u2013H689. https:\/\/doi.org\/10.1152\/ajpheart.00374.2017 (2017).","journal-title":"Am. J. Physiol. Heart. Circ. Physiol."},{"key":"81277_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192114500","author":"A Bahabayi","year":"2022","unstructured":"Bahabayi, A. et al. Expression of Matrix Metalloproteinase-2,-7,-9 in Serum during Pregnancy in Patients with Pre-Eclampsia: A Prospective Study. Int. J. Environ. Res. Public Health https:\/\/doi.org\/10.3390\/ijerph192114500 (2022).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"81277_CR56","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.preghy.2022.03.002","volume":"28","author":"JD Ravn","year":"2022","unstructured":"Ravn, J. D., Bendix, E. J., Sperling, L. & Overgaard, M. First trimester serum matrix metalloproteinase-7 is a poor predictor of late-onset preeclampsia. Preg. Hypertens. 28, 94\u201399. https:\/\/doi.org\/10.1016\/j.preghy.2022.03.002 (2022).","journal-title":"Preg. Hypertens."},{"key":"81277_CR57","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ejogrb.2014.09.027","volume":"182","author":"RE Allen","year":"2014","unstructured":"Allen, R. E., Rogozinska, E., Cleverly, K., Aquilina, J. & Thangaratinam, S. Abnormal blood biomarkers in early pregnancy are associated with preeclampsia: a meta-analysis. Eur. J. Obstet. Gynecol. Reprod Biol. 182, 194\u2013201. https:\/\/doi.org\/10.1016\/j.ejogrb.2014.09.027 (2014).","journal-title":"Eur. J. Obstet. Gynecol. Reprod Biol."},{"key":"81277_CR58","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ejogrb.2010.04.009","volume":"151","author":"O Lapaire","year":"2010","unstructured":"Lapaire, O., Shennan, A. & Stepan, H. The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application. Eur. J. Obstet. Gynecol. Reprod. Biol. 151, 122\u2013129. https:\/\/doi.org\/10.1016\/j.ejogrb.2010.04.009 (2010).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"81277_CR59","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/hr.2010.92","volume":"33","author":"A Molvarec","year":"2010","unstructured":"Molvarec, A. et al. Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia. Hypertens Res. 33, 892\u2013898. https:\/\/doi.org\/10.1038\/hr.2010.92 (2010).","journal-title":"Hypertens Res."},{"key":"81277_CR60","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2023.5292","author":"A Velegrakis","year":"2023","unstructured":"Velegrakis, A., Kouvidi, E., Fragkiadaki, P. & Sifakis, S. Predictive value of the sFlt-1\/PlGF ratio in women with suspected preeclampsia: An update (Review). Int. J. Mol. Med. https:\/\/doi.org\/10.3892\/ijmm.2023.5292 (2023).","journal-title":"Int. J. Mol. Med."},{"key":"81277_CR61","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1159\/000214081","volume":"67","author":"K Kristensen","year":"2009","unstructured":"Kristensen, K. et al. Serum amyloid a protein and C-reactive protein in normal pregnancy and preeclampsia. Gynecol. Obstet. Invest. 67, 275\u2013280. https:\/\/doi.org\/10.1159\/000214081 (2009).","journal-title":"Gynecol. Obstet. Invest."},{"key":"81277_CR62","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1161\/HYPERTENSIONAHA.114.04531","volume":"65","author":"MG Mohaupt","year":"2015","unstructured":"Mohaupt, M. G. C-reactive protein and its role in preeclampsia. Hypertension 65, 285\u2013286. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.114.04531 (2015).","journal-title":"Hypertension"},{"key":"81277_CR63","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1161\/HYPERTENSIONAHA.119.13348","volume":"74","author":"A Leanos-Miranda","year":"2019","unstructured":"Leanos-Miranda, A. et al. Soluble Endoglin As a Marker for Preeclampsia, Its Severity, and the Occurrence of Adverse Outcomes. Hypertension 74, 991\u2013997. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.119.13348 (2019).","journal-title":"Hypertension"},{"key":"81277_CR64","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s11010-021-04294-z","volume":"477","author":"G Margioula-Siarkou","year":"2022","unstructured":"Margioula-Siarkou, G. et al. The role of endoglin and its soluble form in pathogenesis of preeclampsia. Mol. Cell Biochem. 477, 479\u2013491. https:\/\/doi.org\/10.1007\/s11010-021-04294-z (2022).","journal-title":"Mol. Cell Biochem."},{"key":"81277_CR65","doi-asserted-by":"publisher","DOI":"10.11622\/smedj.2017034","author":"S Luewan","year":"2018","unstructured":"Luewan, S., Teja-Intr, M., Sirichotiyakul, S. & Tongsong, T. Low maternal serum pregnancy-associated plasma protein-A as a risk factor of preeclampsia. Singapore Med. J. https:\/\/doi.org\/10.11622\/smedj.2017034 (2018).","journal-title":"Singapore Med. J."},{"key":"81277_CR66","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1515\/jpm-2022-0241","volume":"51","author":"T Kantomaa","year":"2023","unstructured":"Kantomaa, T., Vaarasmaki, M., Gissler, M., Sairanen, M. & Nevalainen, J. First trimester low maternal serum pregnancy associated plasma protein-A (PAPP-A) as a screening method for adverse pregnancy outcomes. J. Perinat Med. 51, 500\u2013509. https:\/\/doi.org\/10.1515\/jpm-2022-0241 (2023).","journal-title":"J. Perinat Med."},{"key":"81277_CR67","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22026","author":"E Das","year":"2022","unstructured":"Das, E., Singh, V., Agrawal, S. & Pati, S. K. Prediction of Preeclampsia Using First-Trimester Uterine Artery Doppler and Pregnancy-Associated Plasma Protein-A (PAPP-A): A Prospective Study in Chhattisgarh India. Cureus https:\/\/doi.org\/10.7759\/cureus.22026 (2022).","journal-title":"Cureus"},{"key":"81277_CR68","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1007\/s43032-023-01176-1","volume":"30","author":"M Uriel","year":"2023","unstructured":"Uriel, M., Romero Infante, X. C., Rincon Franco, S., Ibanez Pinilla, E. A. & Rojas, N. A. Higher PAPP-A Values in Pregnant Women Complicated with Preeclampsia Than with Gestational Hypertension. Reprod. Sci. 30, 2503\u20132511. https:\/\/doi.org\/10.1007\/s43032-023-01176-1 (2023).","journal-title":"Reprod. Sci."},{"key":"81277_CR69","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.preghy.2018.04.010","volume":"12","author":"C Birdir","year":"2018","unstructured":"Birdir, C. et al. Predictive value of sFlt-1, PlGF, sFlt-1\/PlGF ratio and PAPP-A for late-onset preeclampsia and IUGR between 32 and 37 weeks of pregnancy. Pregn. Hypertens. 12, 124\u2013128. https:\/\/doi.org\/10.1016\/j.preghy.2018.04.010 (2018).","journal-title":"Pregn. Hypertens."},{"key":"81277_CR70","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/pd.2339","volume":"29","author":"R D'Anna","year":"2009","unstructured":"D\u2019Anna, R. et al. First trimester serum PAPP-A and NGAL in the prediction of late-onset pre-eclampsia. Prenat. Diagn. 29, 1066\u20131068. https:\/\/doi.org\/10.1002\/pd.2339 (2009).","journal-title":"Prenat. Diagn."},{"key":"81277_CR71","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jri.2019.05.003","volume":"133","author":"PY Robillard","year":"2019","unstructured":"Robillard, P. Y., Dekker, G., Chaouat, G., Elliot, M. G. & Scioscia, M. High incidence of early onset preeclampsia is probably the rule and not the exception worldwide. 20th anniversary of the reunion workshop A summary. J. Reprod. Immunol. 133, 30\u201336. https:\/\/doi.org\/10.1016\/j.jri.2019.05.003 (2019).","journal-title":"J. Reprod. Immunol."},{"key":"81277_CR72","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/uog.26222","volume":"61","author":"DL Rolnik","year":"2023","unstructured":"Rolnik, D. L. et al. ASPRE trial: effects of aspirin on mean arterial blood pressure and uterine artery pulsatility index trajectories in pregnancy. Ultrasound Obstet. Gynecol. 61, 691\u2013697. https:\/\/doi.org\/10.1002\/uog.26222 (2023).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"81277_CR73","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","volume":"132","author":"ACOG Committee Opinion No","year":"2018","unstructured":"ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy. Obstet. Gynecol. 132, e44\u2013e52. https:\/\/doi.org\/10.1097\/AOG.0000000000002708 (2018).","journal-title":"Obstet. Gynecol."},{"key":"81277_CR74","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1080\/14767058.2018.1427718","volume":"32","author":"PG Lan","year":"2019","unstructured":"Lan, P. G. et al. Effect of early use of low-dose aspirin therapy on late-onset preeclampsia. J. Matern. Fetal. Neonatal Med. 32, 2137\u20132142. https:\/\/doi.org\/10.1080\/14767058.2018.1427718 (2019).","journal-title":"J. Matern. Fetal. Neonatal Med."},{"key":"81277_CR75","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/jalm\/jfaa149","volume":"6","author":"HO Fasanya","year":"2021","unstructured":"Fasanya, H. O., Hsiao, C. J., Armstrong-Sylvester, K. R. & Beal, S. G. A Critical Review on the Use of Race in Understanding Racial Disparities in Preeclampsia. J. Appl. Lab. Med. 6, 247\u2013256. https:\/\/doi.org\/10.1093\/jalm\/jfaa149 (2021).","journal-title":"J. Appl. Lab. Med."},{"key":"81277_CR76","doi-asserted-by":"publisher","first-page":"S876","DOI":"10.1016\/j.ajog.2020.07.038","volume":"226","author":"JD Johnson","year":"2022","unstructured":"Johnson, J. D. & Louis, J. M. Does race or ethnicity play a role in the origin, pathophysiology, and outcomes of preeclampsia? An expert review of the literature. Am. J. Obstet. Gynecol. 226, S876\u2013S885. https:\/\/doi.org\/10.1016\/j.ajog.2020.07.038 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"435","key":"81277_CR77","doi-asserted-by":"publisher","first-page":"e431","DOI":"10.1016\/j.ajog.2013.11.039","volume":"210","author":"AA Creanga","year":"2014","unstructured":"Creanga, A. A., Bateman, B. T., Kuklina, E. V. & Callaghan, W. M. Racial and ethnic disparities in severe maternal morbidity: a multistate analysis, 2008\u20132010. Am. J. Obstet. Gynecol. 210(435), e431-438. https:\/\/doi.org\/10.1016\/j.ajog.2013.11.039 (2014).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"81277_CR78","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.annepidem.2019.02.007","volume":"33","author":"SA Leonard","year":"2019","unstructured":"Leonard, S. A., Main, E. K., Scott, K. A., Profit, J. & Carmichael, S. L. Racial and ethnic disparities in severe maternal morbidity prevalence and trends. Ann. Epidemiol. 33, 30\u201336. https:\/\/doi.org\/10.1016\/j.annepidem.2019.02.007 (2019).","journal-title":"Ann. Epidemiol."},{"key":"81277_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.11.015","author":"SJ Korzeniewski","year":"2016","unstructured":"Korzeniewski, S. J. et al. Maternal plasma angiogenic index-1 (placental growth factor\/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study. Am. J. Obstet. Gynecol. https:\/\/doi.org\/10.1016\/j.ajog.2015.11.015 (2016).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"81277_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2022.04.015","author":"R Romero","year":"2022","unstructured":"Romero, R. et al. Toward a new taxonomy of obstetrical disease: improved performance of maternal blood biomarkers for the great obstetrical syndromes when classified according to placental pathology. Am. J. Obstet. Gynecol. https:\/\/doi.org\/10.1016\/j.ajog.2022.04.015 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"81277_CR81","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/bioinformatics\/bty537","volume":"35","author":"MS Ghaemi","year":"2019","unstructured":"Ghaemi, M. S. et al. Multiomics modeling of the immunome, transcriptome, microbiome, proteome and metabolome adaptations during human pregnancy. Bioinformatics 35, 95\u2013103. https:\/\/doi.org\/10.1093\/bioinformatics\/bty537 (2019).","journal-title":"Bioinformatics"},{"key":"81277_CR82","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039324","author":"MC Roland","year":"2012","unstructured":"Roland, M. C. et al. Fetal growth versus birthweight: the role of placenta versus other determinants. Plos One https:\/\/doi.org\/10.1371\/journal.pone.0039324 (2012).","journal-title":"Plos One"},{"key":"81277_CR83","first-page":"330","volume":"66","author":"BM Schroeder","year":"2002","unstructured":"Schroeder, B. M. ACOG practice bulletin on diagnosing and managing preeclampsia and eclampsia. American College of Obstetricians and Gynecologists. Am. Fam. Phys. 66, 330\u2013331 (2002).","journal-title":"Am. Fam. Phys."},{"key":"81277_CR84","doi-asserted-by":"publisher","first-page":"17147","DOI":"10.1038\/s41598-022-22116-0","volume":"12","author":"J Candia","year":"2022","unstructured":"Candia, J., Daya, G. N., Tanaka, T., Ferrucci, L. & Walker, K. A. Assessment of variability in the plasma 7k SomaScan proteomics assay. Sci. Rep. 12, 17147. https:\/\/doi.org\/10.1038\/s41598-022-22116-0 (2022).","journal-title":"Sci. Rep."},{"key":"81277_CR85","doi-asserted-by":"publisher","DOI":"10.1101\/2024.02.09.579724","author":"J Candia","year":"2024","unstructured":"Candia, J. SomaScan Bioinformatics: Normalization, Quality Control, and Assessment of Pre-Analytical Variation. bioRxiv https:\/\/doi.org\/10.1101\/2024.02.09.579724 (2024).","journal-title":"bioRxiv"},{"key":"81277_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0665-2","author":"SA Williams","year":"2019","unstructured":"Williams, S. A. et al. Plasma protein patterns as comprehensive indicators of health. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-019-0665-2 (2019).","journal-title":"Nat. Med."},{"key":"81277_CR87","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","volume":"558","author":"BB Sun","year":"2018","unstructured":"Sun, B. B. et al. Genomic atlas of the human plasma proteome. Nature 558, 73\u201379. https:\/\/doi.org\/10.1038\/s41586-018-0175-2 (2018).","journal-title":"Nature"},{"key":"81277_CR88","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.134838","author":"R Apps","year":"2020","unstructured":"Apps, R. et al. Multimodal immune phenotyping of maternal peripheral blood in normal human pregnancy. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.134838 (2020).","journal-title":"JCI Insight"},{"key":"81277_CR89","unstructured":"R: A language and environment for statistical computing (R Foundation for Statistical Computing, Vienna, Austria, 2020)."},{"key":"81277_CR90","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1093\/bioinformatics\/btm069","volume":"23","author":"W Stacklies","year":"2007","unstructured":"Stacklies, W., Redestig, H., Scholz, M., Walther, D. & Selbig, J. pcaMethods\u2013a bioconductor package providing PCA methods for incomplete data. Bioinformatics 23, 1164\u20131167. https:\/\/doi.org\/10.1093\/bioinformatics\/btm069 (2007).","journal-title":"Bioinformatics"},{"key":"81277_CR91","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucl. Acids Res. 43, e47\u2013e47 (2015).","journal-title":"Nucl. Acids Res."},{"key":"81277_CR92","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J. R. Stat. Soc. 57, 289\u2013300. https:\/\/doi.org\/10.1111\/j.2517-6161.1995.tb02031.x (1995).","journal-title":"J. R. Stat. Soc."},{"key":"81277_CR93","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: Elegant Graphics for Data Analysis","author":"H Wickham","year":"2016","unstructured":"Wickham, H. ggplot2: Elegant Graphics for Data Analysis,\u00a0https:\/\/ggplot2.tidyverse.org (2016)."},{"key":"81277_CR94","unstructured":"Kolde, R. pheatmap: Pretty Heatmaps. R package version 1.0.12, https:\/\/cran.r-project.org\/web\/packages\/pheatmap\/index.html (2019)"},{"key":"81277_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2021.100141","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation https:\/\/doi.org\/10.1016\/j.xinn.2021.100141 (2021).","journal-title":"Innovation"},{"key":"81277_CR96","unstructured":"Carlson, M. org.Hs.eg.db: Genome wide annotation for Human (2021)."},{"key":"81277_CR97","first-page":"18","volume":"2","author":"A Liaw","year":"2002","unstructured":"Liaw, A. & Wiener, M. Classification and Regression by randomForest. R News 2, 18\u201322 (2002).","journal-title":"R News"},{"key":"81277_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman, J., Hastie, T. & Tibshirani, R. Regularization Paths for Generalized Linear Models via Coordinate Descent. J. Stat. Softw. 33, 1\u201322 (2010).","journal-title":"J. Stat. Softw."},{"key":"81277_CR99","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin, X. et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. Bmc Bioinform. 12, 77. https:\/\/doi.org\/10.1186\/1471-2105-12-77 (2011).","journal-title":"Bmc Bioinform."},{"key":"81277_CR100","unstructured":"Kuhn, M. caret: Classification and Regression Training. Astrophysics Source Code Library, ascl:1505. 1003 (2015)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81277-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81277-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81277-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T21:06:40Z","timestamp":1735333600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81277-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,28]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["81277"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-81277-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,28]]},"assertion":[{"value":"27 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30813"}}